EVALUTING TEMPORAL AND BIOCHEMICAL VARIABLES IN SIGHT-THREATENING DIABETIC RETINOPATHY
DOI:
https://doi.org/10.46649/h0x5vg62Keywords:
diabetic retinopathy (DR), Tumor Necrosis Factor Receptor Superfamily A1(TNFRSF1A), Hydroxyeicosatetraenoic acid (HETE12Abstract
This research took place at AL-Sader Medical City's labs and AL-Furat AL-Awsat Hospital, under the Najaf Al-Ashraf Health Directorate / Ministry of Health, Iraq, in the province of Najaf, during the period from January 2025 to January 2026. Blood samples were collected from a total of 120 patients, divided into three groups: patients with diabetic retinopathy and diabetic patient only . An additional control group of healthy individuals 60 was included for comparison total all 180 sample. All samples were handled and processed according to standard laboratory procedures , ranging in age from 40 to 69 years. Of these, 60 patients have retinopathy, which can be either proliferative or non-proliferative and can cause bleeding in the eye. Additionally, 60 patients do not have retinopathy but infected with diabetic mellitus , and 60 patients make up another group contrasted with sixty healthy individuals and control subjects. Diabetic retinopathy It has huge social and economic implications and is still a major cause of blindness in people [1]. Working age and the elderly around the of new biomarkers beyond non-specific indicators such as (Tumor Necrosis Factor Receptor Superfamily A1 (TNFRSF1A) and Hydroxyeicosatetraenoic acid (HETE12).
Published
Issue
Section
License
The Corresponding Author, with the consent of all coauthors, hereby transfers to the FJHMS the copyright ownership in referenced Article, including all versions in any format now known or the hereafter developed. If the Article is not accepted by FJHMS or withdrawn prior to acceptance, this transfer will be null and void.
In order for your article to be distributed as widely as possible your grant the FJHMS an exclusive right to:
- Publish, reproduce, distribute, display, and store the Article in all forms, formats, and media known or later developed (including without limitation in print, digital, and electronic form) throughout the world;
- Translate the Article into other languages, create adaptations, summaries or extracts of the Article or other derivative works based on the Article and exercise all of the rights set forth in (a) above in such translations, adaptations, summaries, extracts, and derivative works;
- License others to do any or all of the above
All accepted Articles become the property of FJHMS and may not be published elsewhere without written permission of the FJHMS
